Viewing Study NCT02734004

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:22 PM
Ignite Modification Date: 2026-02-21 @ 10:11 PM
Study NCT ID: NCT02734004
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-25
First Post: 2016-03-17
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors.
Sponsor: AstraZeneca
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian View
None Breast View
None SCLC View
None Gastric Cancers View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MEDIOLA View
None Olaparib View
None MEDI4736 View
None Bevacizumab View
None Ovarian cancer View
None Breast cancer View
None Small Cell Lung Cancer View
None Gastric Cancer View
None Phase I/II, Adults View
None PDL-1 View